{"id":"W4407036945","doi":"10.20944/preprints202501.1882.v2","title":"Optimal Use of Bispecific Antibodies for the Treatment of Diffuse Large B-cell Lymphoma in Canada","year":2025,"lang":"en","type":"preprint","venue":"Preprints.org","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"AbbVie Canada","keywords":"Bispecific antibody; Lymphoma; Medicine; Antibody; Diffuse large B-cell lymphoma; Refractory (planetary science); Antibody therapy; Chimeric antigen receptor; Oncology; Cancer research; Internal medicine; Immunotherapy; Immunology; Cancer; Monoclonal antibody; Biology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001072456,0.0001491277,0.0002633719,0.0003828683,0.0003235895,0.001273265,0.0002978133,0.0005727974,0.002964052],"category_scores_gemma":[0.001416379,0.0001074188,0.0002464696,0.000388532,0.0004246822,0.00044765,0.0003865753,0.0008124224,0.0009620476],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002626892,"about_ca_system_score_gemma":0.002524946,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.009649835,"about_ca_topic_score_gemma":0.01695615,"domain_scores_codex":[0.9996293,0.0001047734,0.00003220028,0.00004616474,0.0001056561,0.00008194409],"domain_scores_gemma":[0.9997073,0.00004818499,0.00006151802,0.00002377295,0.00007844426,0.00008087632],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.003610662,0.0004114012,0.01672897,0.001080128,0.0001147453,0.002580661,0.0003581243,0.002436965,0.06205546,0.01041422,0.03617335,0.8640351],"study_design_scores_gemma":[0.0009615603,0.002438258,0.05954827,0.00121098,0.0003619374,0.01017885,0.0008111525,0.003518113,0.08857977,0.01060116,0.8217022,0.00008776142],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"other","genre_scores_codex":[0.4450928,0.3078383,0.03205869,0.05932292,0.002002383,0.000508007,0.001332639,0.0009358907,0.1509084],"genre_scores_gemma":[0.9251022,0.04068732,0.01897218,0.005633732,0.0004714514,0.0001059632,0.0006584962,0.0002009357,0.00816789],"genre_candidate":"other","genre_consensus":null,"teacher_disagreement_score":0.9903502,"threshold_uncertainty_score":0.01918733,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1461701691137566,"score_gpt":0.3699330324314396,"score_spread":0.223762863317683,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}